Oriola-KD and Orion renew their cooperation agreement in Finland

Oriola-KD Corporation Stock Exchange Release 1 June 2015 at 8.30 a.m.

Oriola-KD and Orion renew their cooperation agreement in Finland

Oriola-KD Corporation's Finnish subsidiary Oriola Oy and Orion Oyj (Orion) have signed a new long-term cooperation agreement on 29 May 2015. According to the cooperation agreement, Oriola continues to be responsible for Orion's pharmaceutical warehousing and distribution and extensive selection of services in Finland.

Orion is a globally operating Finnish company developing, manufacturing and marketing human and veterinary pharmaceuticals, active pharmaceutical ingredients and diagnostic tests. Orion's wholesale of human pharmaceuticals in Finland in 2014 amounted to EUR 251 million. Orion's market share of Finnish pharmaceuticals market was 12% in 2014 (source: IMS Health). In addition, Orion is the biggest marketer of non-medicinal products in the Finnish pharmacy field and a significant marketer of veterinary pharmaceuticals.

Oriola-KD Corporation

Eero Hautaniemi

President and CEO

For further information, please contact:

Eero Hautaniemi
President and CEO
tel. +358 10 429 2109
eero.hautaniemi@oriola-kd.com

Distribution:

NASDAQ OMX Helsinki Ltd.
Key media

Released by:

Oriola-KD Corporation
Corporate Communications
Orionintie 5
FI-02200 Espoowww.oriola-kd.com

HUG#1925211